Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ADAM11 |
| Upstream (Parents) |
|---|
| (<<) ANGPT1 → ADAM11 |
| (<<) DDN → ADAM11 |
| (<<) RUNX1T1 → ADAM11 |
| (<<) ZEB1 → ADAM11 |
| (<<) SPATS2L → ADAM11 |
| (<<) NID1 → ADAM11 |
| Downstream (Children) |
|---|
| ADAM11 → PGLYRP1 (>>) |
| ADAM11 → HIP1R (>>) |
| ADAM11 → APOL2 (>>) |
| ADAM11 → RAB3A (>>) |
| ADAM11 → CRISP3 (>>) |
| ADAM11 → RBPMS (>>) |
| ADAM11 → TMSB15B///TMSB15A (>>) |
| ADAM11 → TMOD2 (>>) |
| ADAM11 → RBM12B (>>) |
